CDC Reviews Flu Vaccines for 65+

The CDC’s Advisory Committee on Immunization Practices (ACIP) is currently reviewing enhanced influenza vaccines (EIV), which are shots recommended to best protect adults 65+ who may be more vulnerable.    Returning guest, Dr. Gregg Sylvester, Chief Medical Officer at Seqirus, one of the world’s largest influenza providers, discusses enhanced flu vaccines and their importance; flu vaccine options, including factors impacting vaccine effectiveness  in older adults; and how flu vaccinations have evolved in the last decade since the last CDC  Committee review. 

Dr Gregg Sylvester has led Seqirus Medical Affairs since 2016, overseeing the global team that scientifically differentiates our vaccines by generating Real World Evidence and presenting Seqirus research to national vaccine recommending organizations. Gregg has extensive experience in the pharmaceutical industry, government and patient care. Prior to joining Seqirus, he led Medical Affairs teams in the worldwide launches of Gardasil, Prevnar 13 and Trumenba. Gregg obtained specialty boards in Pediatrics and General Preventive Medicine. Augmenting his clinical expertise, he served in the CDC Epidemic Intelligence Service and as a Public Policy Fellow in the U.S. Congress. During his distinguished career in state government, Gregg was appointed to the Cabinet Secretary for Health and Social Services in Delaware, leading the state’s largest agency. Gregg has a MD from Albany Medical College and an MPH from the Johns Hopkins Bloomberg School of Public Health.

Liked it? Take a second to support healthprofessionalradio on Patreon!


Leave a Reply

You must be logged in to post a comment.